The risk of recurrence and death was significantly reduced by concurrent treatment with cisplatinand radiotherapy .
Although this regimen was also associated with higher rates of adverse effects , these effects consisted predominantly of transient hematologic and gastrointestinal effects , with no evidence of an increase in other serious effects .
